Sep 16, 2022
Season One / Episode Seven The Patient-to-Patient Podcast
Fewer Sexual Issues?
For today's adventure, we travel to the Continent of North America, specifically to the United States, to meet Ronald A. Morton, JR, MD, the Chief Medical Officer of the Urology and Pelvic Health division of Boston Scientific. Dr. Ron and I discussed a procedure pioneered by Boston Scientific and one I was unaware of before my prostatectomy. I know that you will enjoy meeting Dr. Morton. Perhaps after listening to our discussion, this procedure utilizing SpaceOAR Hydrogel may be an option for you.
Dr. Ronald Morton Jr
Dr. Mortons Bio Doctor of Physical Therapy, Sexual Health Counselor, Sexual Health Educator
Ronald A. Morton, JR, MD, FACS, is the Chief Medical Officer of the Urology and Pelvic Health division of Boston Scientific. Before joining Boston Scientific via acquisition, Morton worked for Endo International plc as a chief surgical officer at American Medical Systems. Previously, he worked as a chief medical officer for GTx, a biotech company in Memphis, TN. Before joining GTx, Morton was chief of urology at Robert Wood Johnson Medical School and director of urologic oncology for the Cancer Institute of New Jersey. He also held an endowed chair position as director of the General Clinical Research Center. Morton holds a BA in natural sciences from The Johns Hopkins University and received his medical doctorate from The Johns Hopkins University School of Medicine. He has board certification as a diplomat, American Board of Urology.
Main Topics Discussed
* What Is SpaceOAR Hydrogel, And When Did It First Come On The Market?
* Complications From Radiation Avoided?
* What Is The Risk Reward?
* In what Countries Is This Option Available
* How This Procedure Preserves Quality Of Life After Surgery
* Other Products From Boston Scientific Important Links